Drug Shortage Report for TWYNSTA

Last updated on 2021-01-16 History
Report ID 131370
Drug Identification Number 02371022
Brand name TWYNSTA
Common or Proper name TWYNSTA 40/5MG 4X7
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Market Status MARKETED
Active Ingredient(s) TELMISARTAN AMLODIPINE
Strength(s) 40MG 5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size BLISTER PACK 4X7
ATC code C09DB
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-01-12
Actual start date 2021-01-11
Estimated end date 2021-01-20
Actual end date 2021-01-15
Shortage status Resolved
Updated date 2021-01-16
Company comments
Health Canada comments
Contact Address 5180 SOUTH SERVICE ROAD
BURLINGTON, ONTARIO
CANADA L7L 5H4
Company contact information 1800 263 2425

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-01-16 English Compare
v5 2021-01-15 French Compare
v4 2021-01-15 English Compare
v3 2021-01-12 English Compare
v2 2021-01-11 French Compare
v1 2021-01-11 English Compare